Latest from OSC19
Computational Modeling and Drug Discovery
How do scientists discover drug therapies for diseases such as COVID-19? Many researchers identify potential therapies based on molecular binding affinity—the strength of pharmaceutical binding—to a protein that’s pertinent to disease progression. Historically, this has involved extensive lab work: experimental examinations of the binding affinity of each molecule. Lab work is slow and expensive. ThereContinue reading “Computational Modeling and Drug Discovery”
Our COVID19 Research
Dr. Ho Leung Ng, a professor at Kansas State University, founded the global OSC-19 research consortium in March 2020. His laboratory has successful experience in computational and structure-based drug discovery projects. Dr. Ng will use this expertise to help OSC-19 succeed, and help save as many lives from COVID-19. OSC-19’s research results will be freelyContinue reading “Our COVID19 Research”
How are we helping?
The Open Source COVID-19 (OSC-19) research consortium is merging computer science and biochemistry to quickly, cheaply screen millions of possible drug molecules against COVID-19. The focus of the OSC-19 program is on drugs that are already approved for clinical use. That way, the possible drugs identified by OSC-19 won’t have unexpected, dangerous side effects. UnacceptableContinue reading “How are we helping?”
Support us through GoFundMe: https://gofund.me/027a1c6a
Latest from OSC19
Why is COVID-19 incurable today?
Doctors currently have no proven drugs to treat COVID-19, and as of today a vaccine is many months away. However, the virus has already killed hundreds of thousands. Slow experimental work for devising drug therapies isn’t fast enough; scientists need to dramatically speed up how they identify effective antiviral drug therapies.
Get updates delivered directly
to your inbox.
